First Amendment, dated as of March 23, 2018, to the Credit Agreement dated as of November 17, 2017, entered into by Stericycle, Inc. and certain of its subsidiaries as borrowers, Bank of America, N.A., as administrative agent and the financial institutions from time to time party thereto

EX-10.1 2 d556119dex101.htm FIRST AMENDMENT TO CREDIT AGREEMENT First Amendment to Credit Agreement

Exhibit 10.1

EXECUTION VERSION

STERICYCLE, INC.

FIRST AMENDMENT

This FIRST AMENDMENT, dated as of March 23, 2018 (this “Amendment”), is entered into by and among STERICYCLE, INC., a Delaware corporation (the “Company”), the Subsidiaries of the Company signatory hereto (collectively, the “Subsidiary Loan Parties”), the Lenders (as defined below) signatory hereto and BANK OF AMERICA, N.A., as administrative agent (in such capacity, the “Administrative Agent”) under that certain Credit Agreement, dated as of November 17, 2017 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Credit Agreement”), among the Company, the financial institutions from time to time party thereto as lenders (the “Lenders”) or as “L/C Issuers”, the Subsidiaries of the Company party thereto as “Designated Borrowers”, and the Administrative Agent. Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to them in the Credit Agreement.

W I T N E S S E T H

WHEREAS, the Company has requested that the Lenders and the Administrative Agent amend the Credit Agreement as set forth herein; and

WHEREAS, the Administrative Agent and the Lenders have agreed, on the terms and conditions set forth below, to so amend the Credit Agreement.

NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, each of the parties hereto hereby agrees as follows:

1. Amendments to Credit Agreement. Subject to the satisfaction of the conditions precedent set forth in Section 2 hereof:

(a) The definition of “Applicable Rate” in Section 1.01 is amended to (i) delete the first reference therein to “Pricing Level IV” and insert “Pricing Level V” in lieu thereof and (ii) delete the pricing grid therein and insert the following in lieu thereof:

 

              Revolving Credit Facility   Term Facility

Level

  

Consolidated Leverage Ratio

   Facility
Fee
  Eurocurrency
Rate/Letter of
Credit Fee
  Base Rate   Eurocurrency Rate   Base Rate

I

   Less than 1.75 to 1.00    0.100%   0.900%   0.000%   1.000%   0.000%

II

   Greater than or equal to 1.75 to 1.00 but less than 2.50 to 1.00    0.120%   0.980%   0.000%   1.110%   0.110%

III

   Greater than or equal to 2.50 to 1.00 but less than 3.25 to 1.00    0.150%   1.050%   0.050%   1.200%   0.200%

IV

   Greater than or equal to 3.25 to 1.00 but less than 4.00 to 1.00    0.200%   1.175%   0.175%   1.375%   0.375%

V

   Greater than or equal to 4.00 to 1.00    0.250%   1.375%   0.375%   1.625%   0.625%


(b) The definition of “Consolidated EBITDA” in Section 1.01 is amended to add a new clause (a)(xi) to such definition that reads as follows:

and (xi) solely for purposes of determining compliance with Section 7.11 for any fiscal quarter ending during the period from March 31, 2018 through December 31, 2019 (and for no other purposes hereunder, including, without limitation, for determination of the “Applicable Rate”), up to $200,000,000 in the aggregate in any four-fiscal quarter period of cash charges associated with (A) implementation of the Company’s Business Transformation and Operational Optimization Expenses (each, as described in the Company’s Form 10-K for the fiscal year ended December 31, 2017), (B) internal control remediation, accounting pronouncements and related professional and consulting expenses, (C) legal and settlement related expenses and (D) up to $25,000,000 of other cash charges

(c) The existing Exhibit D is deleted and the Exhibit D attached hereto as Annex A is inserted in lieu thereof.

2. Conditions to Effectiveness. The provisions of Section 1 of this Amendment shall be deemed to have become effective as of the date of this Amendment, but such effectiveness shall be expressly conditioned upon the following:

(a) the Administrative Agent’s receipt of counterparts of this Amendment, duly executed and delivered on behalf of each of the Company, each Subsidiary Loan Party and the Required Lenders;

(b) the Company having paid the fees in the amounts and at the times specified in the letter agreement, dated as of March 1, 2018, between the Company and Merrill Lynch, Pierce, Fenner & Smith Incorporated (the “Amendment Fee Letter”), which fees shall be deemed fully earned and due on the effective date and shall be non-refundable;

(c) satisfactory evidence of substantially contemporaneous amendments in form and substance satisfactory to the Administrative Agent, including amendments in substance parallel to those in Section 1 of this Amendment, with respect to (x) the 2010 Note Purchase Agreement, (y) the 2012 Note Purchase Agreement, and (z) the 2015 Note Purchase Agreement; and

(d) unless waived by the Administrative Agent, the Company having paid all fees, charges and disbursements of counsel to the Administrative Agent to the extent invoiced prior to the date hereof.

3. Representations and Warranties. Each Loan Party hereby represents and warrants that:

(a) This Amendment has been duly executed and delivered by each Loan Party that is party hereto. This Amendment constitutes a legal, valid and binding obligation of such Loan Party, enforceable against such Loan Party in accordance with its terms (except, in any case, as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, examinership or similar laws affecting creditors’ rights generally and by principles of equity);

(b) Each Loan Party (i) is duly organized or formed, validly existing and in good standing (if applicable in such Loan Party’s jurisdiction of incorporation or organization) under the Laws of the jurisdiction of its incorporation or organization and (ii) has all requisite power and authority and all requisite governmental licenses, authorizations, consents and approvals to execute, deliver and perform its obligations under this Amendment;

 

2


(c) The execution, delivery and performance by each Loan Party of this Amendment have been duly authorized by all necessary corporate or other organizational action, and do not and will not (i) contravene the terms of any of such Person’s Organization Documents; (ii) conflict with or result in any breach or contravention of, or the creation of any Lien under, or require any payment to be made under (A) any Contractual Obligation to which such Person is a party or affecting such Person or the properties of such Person or any of its Subsidiaries or (B) any order, injunction, writ or decree of any Governmental Authority or any arbitral award to which such Person or its property is subject; or (iii) violate any Law;

(d) No approval, consent, exemption, authorization, or other action by, or notice to, or filing with, any Governmental Authority or any other Person is necessary or required in connection with the execution, delivery or performance by, or enforcement against, any Loan Party of this Amendment;

(e) No Default has occurred and is continuing or would result from the consummation of the transactions contemplated by this Amendment; and

(f) The representations and warranties contained in Article V of the Credit Agreement and the other Loan Documents are true and correct in all material respects (except to the extent any such representation and warranty is qualified by materiality or reference to Material Adverse Effect, in which case, such representation and warranty shall be true and correct in all respects) on and as of the date hereof, except to the extent that such representations and warranties specifically refer to an earlier date, in which case they are true and correct in all material respects (except to the extent any such representation and warranty is qualified by materiality or reference to Material Adverse Effect, in which case, such representation and warranty shall be true and correct in all respects) as of such earlier date and except that the representations and warranties contained in subsections (a) and (b) of Section 5.05 thereof shall be deemed to refer to the most recent statements furnished pursuant to clauses (a) and (b), respectively, of Section 6.01 thereof.

4. Governing Law; Jurisdiction; Waiver of Jury Trial; Etc. THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS AND DECISIONS (AS OPPOSED TO CONFLICTS OF LAW PROVISIONS) OF THE STATE OF NEW YORK. This Amendment shall be further subject to the provisions of Sections 10.14 and 10.15 of the Credit Agreement.

5. Counterparts; Integration; Effectiveness. This Amendment may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Amendment, together with the Amendment Fee Letter and the other Loan Documents, constitutes the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. Delivery of an executed counterpart of a signature page of this Amendment by telecopy or other electronic imaging means shall be effective as delivery of a manually executed counterpart of this Amendment.

6. Severability. If any provision of this Amendment is held to be illegal, invalid or unenforceable, (a) the legality, validity and enforceability of the remaining provisions of this Amendment shall not be affected or impaired thereby and (b) the parties shall endeavor in good faith negotiations to replace the illegal, invalid or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the illegal, invalid or unenforceable provisions. The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

3


7. Effect. Upon the effectiveness of this Amendment, each reference in the Credit Agreement to “this Agreement,” “hereunder,” “hereof” or words of like import shall mean and be a reference to the Credit Agreement as modified hereby and each reference in the other Loan Documents to the Credit Agreement, “thereunder,” “thereof,” or words of like import shall mean and be a reference to the Credit Agreement as modified hereby. This Amendment shall constitute a Loan Document for purposes of the Credit Agreement.

8. Reaffirmation. Except as specifically modified by this Amendment, the Credit Agreement shall remain in full force and effect and is hereby ratified and confirmed.

9. Guarantors. Each Guarantor hereby consents to this Amendment and reaffirms the terms and conditions of each Guaranty and each other Loan Document executed by it and acknowledges and agrees that each and every such Guaranty and other Loan Document executed by such Guarantor in connection with the Credit Agreement remains in full force and effect and is hereby reaffirmed, ratified and confirmed.

[Remainder of this page intentionally left blank; signature pages follow]

 

4


IN WITNESS WHEREOF, each of the undersigned has caused this Amendment to be executed and delivered by a duly authorized officer on the date first above written.

 

BANK OF AMERICA, N.A.,

as Administrative Agent

By:  

/s/ Ronaldo Naval

Name:   Ronaldo Naval
Title:   Vice President
BANK OF AMERICA, N.A., as a Lender, an L/C Issuer and Swing Line Lender
By:  

/s/ Matthew N. Walt

Name:   Matthew N. Walt
Title:   Director

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


STERICYCLE, INC., as the Company
By:  

/s/ Daniel Ginnetti

Name:   Daniel Ginnetti
Title:   Executive Vice President and Chief Financial Officer
STERICYCLE INTERNATIONAL, LTD., as a Designated Borrower and a Guarantor
By:  

/s/ Daniel Ginnetti

Name:   Daniel Ginnetti
Title:   Director
SRCL LIMITED, as a Designated Borrower and a Guarantor

 

By:  

/s/ Daniel Ginnetti

Name:   Daniel Ginnetti
Title:   Director

 

STERICYCLE EUROPE S.à.r.l., as a Designated Borrower and a Guarantor
By:  

/s/ Daniel Ginnetti

Name:   Daniel Ginnetti
Title:   A manager
STERICYCLE, ULC, as a Designated Borrower and a Guarantor
By:  

/s/ Daniel Ginnetti

Name:   Daniel Ginnetti
Title:   Executed Vice President and Chief Financial Officer
STERICYCLE INTERNATIONAL HOLDINGS LIMITED, as a Designated Borrower and a Guarantor
By:  

/s/ Daniel Ginnetti

Name:   Daniel Ginnetti
Title:   Director

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


STERICYCLE ENVIRONMENTAL SOLUTIONS, INC., as a Guarantor
By:  

/s/ Daniel Ginnetti

Name:   Daniel Ginnetti
Title:   Vice President, Secretary and Treasurer
SHRED-IT USA LLC, as a Guarantor
By:  

/s/ Daniel Ginnetti

Name:   Daniel Ginnetti
Title:   Vice President, Secretary and Treasurer
STERICYCLE COMMUNICATION SOLUTIONS, INC., as a Guarantor
By:  

/s/ Daniel Ginnetti

Name:   Daniel Ginnetti
Title:   Vice President, Secretary and Treasurer

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


STERICYCLE ESPAÑA, S.L. (Sociedad Unipersonal),

as a Guarantor

 

By:  

/s/ Franciscus J.M. Ten Brink

Name:   Franciscus J.M. Ten Brink
Title:   Administrador Único

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


HSBC BANK USA, NATIONAL ASSOCIATION, as a Lender
By:  

/s/ Matthew Brannon

Name:   Matthew Brannon
Title:   Vice President

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


HSBC BANK PLC, as a Lender
By:  

/s/ Giovanna Padua

Name:   Giovanna Padua
Title:   Relationship Banker

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


JPMORGAN CHASE BANK, N.A., as a Lender
By:  

/s/ Krys Szrenski

Name:   Krys Szrenski
Title:   Executive Director

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., as a Lender
By:  

/s/ Maria F. Maia

Name:   Maria Maia
Title:   Director

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


SUMITOMO MITSUI BANKING CORPORATION, as a Lender
By:  

/s/ James D. Weinstein

Name:   James D. Weinstein
Title:   Managing Director

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


WELLS FARGO BANK, NATIONAL ASSOCIATION, as a Lender
By:  

/s/ Sara Barton

Name:   Sara Barton
Title:   Vice President

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


U.S. BANK NATIONAL ASSOCIATION, as a Lender
By:  

/s/ James DeVries

Name:   James DeVries
Title:   Senior Vice President

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


BMO HARRIS FINANCING INC., as a Lender
By:  

/s/ Isabella Battista

Name:   Isabella Battista
Title:   Director

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


BMO HARRIS BANK N.A., as a Lender
By:  

/s/ Isabella Battista

Name:   Isabella Battista
Title:   Director

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


COMPASS BANK, as a Lender
By:  

/s/ April Chan

Name:  
Title:  

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


UNICREDIT BANK AG, NEW YORK BRANCH, as a Lender
By:  

/s/ Ken Hamilton

Name:   Ken Hamilton
Title:   Managing Director
By:  

/s/ Mathias Eichwald

Name:   Mathias Eichwald
Title:  

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


GOLDMAN SACHS BANK USA, as a Lender
By:  

/s/ Chris Lam

Name:   Chris Lam
Title:  

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


CITIBANK, N.A., as a Lender
By:  

/s/ Michael Schadt

Name:   Michael Schadt
Title:   Authorized Signatory

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


CITIZENS BANK, N.A., as a Lender
By:  

/s/ Caroline Conole

Name:   Caroline Conole
Title:   Assistant Vice President

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


PNC BANK, NATIONAL ASSOCIATION, as a Lender
By:  

/s/ Bridget Anderson

Name:   Bridget Anderson
Title:   Assistant Vice President

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


SANTANDER BANK, N.A., as a Lender
By:  

/s/ Andres Barbosa

Name:   Andres Barbosa
Title:   Executive Director
By:  

/s/ Daniel Kostman

Name:   Daniel Kostman
Title:   Executive Director

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


THE NORTHERN TRUST COMPANY, as a Lender
By:  

/s/ Brittany Mondanc

Name:   Brittany Mondanc
Title:   Vice President

 

Stericycle, Inc.

First Amendment to Credit Agreement

Signature Page


ANNEX A

EXHIBIT D

FORM OF COMPLIANCE CERTIFICATE

Financial Statement Date:                     ,         

To: Bank of America, N.A., as Administrative Agent

Ladies and Gentlemen:

Reference is made to that certain Credit Agreement, dated as of November 17, 2017 (as amended, restated, extended, supplemented or otherwise modified in writing from time to time, the “Agreement;” the terms defined therein being used herein as therein defined), among Stericycle, Inc., a Delaware corporation (the “Company”), the Designated Borrowers from time to time party thereto, the Lenders from time to time party thereto, and Bank of America, N.A., as Administrative Agent, Swing Line Lender and an L/C Issuer.

The undersigned Responsible Officer hereby certifies as of the date hereof that he/she is the                                 of the Company, and that, as such, he/she is authorized to execute and deliver this Certificate to the Administrative Agent on the behalf of the Company, and that:

[Use following paragraph 1 for fiscal year-end financial statements]

1. Attached hereto as Schedule 1 are the year-end audited financial statements required by Section 6.01(a) of the Agreement for the fiscal year of the Company ended as of the above date, together with the report and opinion of an independent certified public accountant required by such section.

[Use following paragraph 1 for fiscal quarter-end financial statements]

1. Attached hereto as Schedule 1 are the unaudited financial statements required by Section 6.01(b) of the Agreement for the fiscal quarter of the Company ended as of the above date. Such financial statements fairly present the financial condition, results of operations and cash flows of the Company and its Consolidated Subsidiaries in accordance with GAAP as at such date and for such period, subject only to normal year-end audit adjustments and the absence of footnotes.

2. The undersigned has reviewed and is familiar with the terms of the Agreement and has made, or has caused to be made under his/her supervision, a detailed review of the transactions and condition (financial or otherwise) of the Company during the accounting period covered by the attached financial statements.

3. A review of the activities of the Company during such fiscal period has been made under the supervision of the undersigned with a view to determining whether during such fiscal period the Company performed and observed all its Obligations under the Loan Documents, and

[select one:]

[to the best knowledge of the undersigned during such fiscal period, the Company performed and observed each covenant and condition of the Loan Documents applicable to it, and no Default has occurred and is continuing.]


–or–

[the following covenants or conditions have not been performed or observed and the following is a list of each such Default and its nature and status:]

4. The representations and warranties of (i) the Borrowers contained in Article V of the Agreement and (ii) each Loan Party contained in each other Loan Document or in any document furnished at any time under or in connection with the Loan Documents, are true and correct in all material respects (except to the extent any such representation and warranty is qualified by materiality or reference to Material Adverse Effect, in which case, such representation and warranty shall be true and correct in all respects) on and as of the date hereof, except to the extent that such representations and warranties specifically refer to an earlier date, in which case they are true and correct in all material respects (except to the extent any such representation and warranty is qualified by materiality or reference to Material Adverse Effect, in which case, such representation and warranty shall be true and correct in all respects) as of such earlier date, and except that for purposes of this Compliance Certificate, the representations and warranties contained in subsections (a) and (b) of Section 5.05 of the Agreement shall be deemed to refer to the most recent statements furnished pursuant to clauses (a) and (b), respectively, of Section 6.01 of the Agreement, including the statements in connection with which this Compliance Certificate is delivered.

5. The financial covenant analyses and information set forth on Schedule 2 attached hereto are true and accurate on and as of the date of this Certificate.

6. Since the date of delivery of the most recent Compliance Certificate, no Persons have become Material Subsidiaries [other than                    ].

[signature page follows]


IN WITNESS WHEREOF, the undersigned has executed this Certificate as of                     ,         .

 

STERICYCLE, INC.
By:                                                                      
Name:                                                                 
Title:                                                                   


For the Quarter/Year ended                      (“Statement Date”)

SCHEDULE 2

to the Compliance Certificate

($ in 000’s)

 

I. Section 7.11 (a) – Consolidated Interest Coverage Ratio.

 

  A. Consolidated EBITDA for four consecutive fiscal quarters ending on above date (“Subject Period”):

 

1.    Consolidated Net Income for Subject Period:    $                     
2.    Consolidated Interest Charges for Subject Period:    $                     
3.    Provision for income taxes for Subject Period:    $                     
4.    Depreciation expenses for Subject Period:    $                     
5.    Amortization expenses for Subject Period:    $                     
6.    Non-recurring non-cash reductions of Consolidated Net Income for Subject Period:    $                     
7.    Non-cash stock compensation expenses incurred in the Subject Period:    $                     
8.    Cash charges associated with the settlement of the TCPA Action (subject to a $45,000,000 aggregate cap) incurred in the Subject Period:    $                     
9.    Cash charges associated with the settlement of the MDL Contract Action (subject to a $295,000,000 aggregate cap) incurred in the Subject Period:    $                     
10.    Cash charges related to legal fees and expenses associated with the MDL Contract Action and related amendments to the Existing Credit Agreements and Senior Notes (subject to a $5,000,000 aggregate cap) incurred in the Subject Period:    $                     
12    Transaction Costs for Subject Period:    $                     
13.    Extraordinary and non-recurring cash expenses or charges (subject to a $10,000,000 aggregate cap) for Subject Period:    $                     


14.    Up to $200,000,000 in the aggregate in any four-fiscal quarter period of cash charges associated with (A) implementation of the Company’s Business Transformation and Operational Optimization Expenses (each, as described in the Company’s Form 10-K for the fiscal year ended December 31, 2017), (B) internal control remediation, accounting pronouncements and related professional and consulting expenses, (C) legal and settlement related expenses and (D) up to $25,000,000 of other cash charges:1    $                     
15.    Income tax credits for Subject Period:    $                     
16.    Non-cash additions to Consolidated Net Income for Subject Period:    $                     
17.    Consolidated EBITDA (Lines I.A.1 + 2 + 3 + 4 + 5 + 6 +7 + 8 + 9 + 10 + 11 + 12 + 13 + 14 – 15 - 16):    $                     

 

B.    Consolidated Interest Charges for Subject Period:    $                     
C.    Consolidated Interest Coverage Ratio (Line I.A.17 ÷Line I.B):                 to 1.00
D.    Minimum Permitted:    3.00 to 1.00

 

II. Section 7.11 (b) – Consolidated Leverage Ratio.2

 

A.    Consolidated Funded Indebtedness at Statement Date    $                     
B.    Unrestricted Cash at Statement Date    $                     
C.    Consolidated EBITDA for Subject Period (Line I.A.17 above):    $                     
D.    Consolidated Leverage Ratio ((Line II.A – Line II.B) ÷ Line II.C):                 to 1.00
E.    Maximum Permitted:    3.75 to 1.00
F.    Consolidated Leverage Ratio for Subject Period for Pricing Grid Purposes ((Line II.A – Line II.B) ÷ (Line II.C – Line I.A.14)):                 to 1.00

 

1  Solely for purposes of determining compliance with Section 7.11 of the Credit Agreement for any fiscal quarter ending during the period from March 31, 2018 through December 31, 2019 (and for no other purposes under the Credit Agreement, including, without limitation, for determination of the “Applicable Rate”).
2  If the Consolidated Leverage Ratio, on a pro forma basis as of any such date and immediately after giving effect to the settlement payment of the MDL Contract Action is greater than 3.50 to 1.00, the Company may, in its sole discretion, elect to increase the maximum Consolidated Leverage Ratio permitted by Section 7.11(b) of the Credit Agreement to 4.00 to 1.00 as of the end of the fiscal quarter in which the settlement of the MDL Contract Action occurred and in any subsequent fiscal quarter ending on or prior to September 30, 2018; provided, further, in no event shall the elevated ratio permitted by the immediately preceding proviso extend after September 30, 2018. Such election shall be made by the delivery of a written notice by the Company to the Administrative Agent making reference to Section 7.11(b) of the Credit Agreement and notifying the Administrative Agent of the Company’s election to increase the maximum Consolidated Leverage Ratio as provided above on or prior to the date of the actual or required delivery of a Compliance Certificate for the fiscal quarter in which the settlement of the MDL Contract Action occurred.